BlackRock Inc (BLK)vsBlackRock Health Sciences Trust II (BMEZ)
BLK
BlackRock Inc
$1,216.95
-0.79%
FINANCIAL SERVICES · Cap: $186.45B
BMEZ
BlackRock Health Sciences Trust II
$17.29
-1.26%
FINANCIAL SERVICES · Cap: $1.10B
Smart Verdict
WallStSmart Research — data-driven comparison
BLK leads profitability with a 24.2% profit margin vs 0.0%. BMEZ trades at a lower P/E of 5.2x. BLK earns a higher WallStSmart Score of 73/100 (B).
BLK
Strong Buy73
out of 100
Grade: B
BMEZ
Avoid30
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 37.9%
Large-cap with strong market position
Keeps 24 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Growing faster than its price suggests
19.1% revenue growth
Attractively priced relative to earnings
Conservative balance sheet, low leverage
Areas to Watch
Moderate valuation
Weak financial health signals
Distress zone — elevated risk
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 5.7% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : BLK
The strongest argument for BLK centers on Operating Margin, Market Cap, Profit Margin. Profitability is solid with margins at 24.2% and operating margin at 37.9%. Revenue growth of 19.1% demonstrates continued momentum.
Bull Case : BMEZ
The strongest argument for BMEZ centers on P/E Ratio, Debt/Equity.
Bear Case : BLK
The primary concerns for BLK are P/E Ratio, Piotroski F-Score, Altman Z-Score.
Bear Case : BMEZ
The primary concerns for BMEZ are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
BLK profiles as a growth stock while BMEZ is a value play — different risk/reward profiles.
BLK is growing revenue faster at 19.1% — sustainability is the question.
BLK generates stronger free cash flow (2.6B), providing more financial flexibility.
Monitor ASSET MANAGEMENT industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BLK scores higher overall (73/100 vs 30/100), backed by strong 24.2% margins and 19.1% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BlackRock Inc
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
BlackRock, Inc. is an American multinational investment management corporation based in New York City.
BlackRock Health Sciences Trust II
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
BlackRock Health Sciences Trust II (BMEZ) is a closed-end fund that focuses on delivering high total returns through a diversified portfolio primarily concentrated in the health sciences sector, which encompasses pharmaceuticals, biotechnology, and medical devices. Capitalizing on BlackRock's extensive industry knowledge, BMEZ targets significant growth opportunities driven by demographic shifts and increasing healthcare spending. With its disciplined investment approach and commitment to funding innovative healthcare solutions, BMEZ provides institutional investors a compelling avenue for portfolio enhancement in a dynamic and rapidly evolving market landscape.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?